IN-VITRO INTERACTION OF SOLUBLE AND AMYLOID FORM OF SERUM AMYLOID A PROTEIN TO NEURO 2A CELLS by Chinnasamy, Asokan
   Asokan Chinnasamy* et al. 
  (IJITR) INTERNATIONAL JOURNAL OF INNOVATIVE TECHNOLOGY AND RESEARCH 
Volume No.3, Issue No.5, August - September 2015, 2390 – 2397. 
2320 –5547 @ 2013 http://www.ijitr.com All rights Reserved.  Page | 2390 
IN-VITRO Interaction of Soluble and Amyloid 
Form of Serum Amyloid a Protein to NEURO 2A 
CELLS 
ASOKAN CHINNASAMY 
          Professor 
Department of Biochemistry, 
Sokoto State University, Sokoto. 
Sokoto State. Nigeria. 
Abstract—Accumulation of Serum amyloid A and fibrillar form is strongly associated with Chronic 
inflammatory disease. Cell membrane binding study is especially important in relation to the activity of 
membrane proteins, because losing the activity of such systems will ultimately lead to malfunction or 
death of the cell.  Serum amyloid A fibrils species are potent neurotoxins, however the molecular 
mechanism responsible for amyloid toxicity is still unknown. The interactions of Serum Amyloid A (SAA) 
and Serum Amyloid A protofibrils with neuro 2a cells of the mouse are dealt with in detail to study the 
binding of SAA protofibrils in various conditions. The FACScan and MTT assay results have shown the 
SAA and SAA fibrils binding and cell toxicity with the Neuro 2a cells. Specifically, interaction of serum 
amyloid A fibrils with a cell surface binding site/receptor might alter the local environment to cause 
cellular dysfunction and to be more favorable for amyloid formation. Previous study have shown RAGE 
(receptor for advanced glycation endproducts) a polyvalent receptor in the immunoglobulin super family 
has been implicated in binding with the isoform of SAA (SAA1.1) which has the highest fibirillogenic 
property. In the present study, concluding the SAA fibrils more binding and cell cytotoxicity than SAA 
protein. 
I. INTRODUCTION 
The cell membrane is a dynamic entity, containing 
highly organized proteins, which are under constant 
thermal perturbation. The integrity of the 
membrane is maintained by the dynamic lipid 
matrix by acting as a thermal sink. Oxidative and 
ionic perturbations are other cellular insults. 
Various transporters nullify the ion fluctuation 
effects. The thermal fluctuations are transduced to 
the system through the cell membrane, and hyper 
thermal effects get attenuated through the 
expression of the heat shock proteins. The cells are 
protected from oxidative insults by the various anti 
oxidant mechanisms. The membrane is damaged 
when these intricate balances are lost. The 
interaction with toxic amyloid fibrils is another 
type of cellular insult for which the mechanism is 
not yet known. Explanations like oxidative and 
ionic imbalance are being given with a lot of 
experimental evidence. Recently, membrane-
stabilized protofibrillar structures were implicated 
in amyloid-related toxicity to mammalian cellular 
system with membrane-amyloid interaction as the 
central point of focus in the understanding of 
amyloid chemistry. Yet another hypothesis predicts 
the specific denaturing ability of amyloid fibrils on 
interacting with native proteins. This is further 
supported by the research findings that amyloid 
have a very high structure breaking effect on vital 
proteins. Several groups have reported the loss of 
membrane-bound enzymatic activity due to 
amyloid interaction.  Amyloid is one protein 
known to have anti chaperonic activity with very 
high membrane binding property.  The toxic 
mechanism of any amyloid depends upon the 
specific and non-specific binding effect of amyloid 
assemblages in various forms. 
The SAA proteins are highly conserved and 
ubiquitous in all vertebrate systems. They belong to 
the apolipoprteins (apoSAA) and are mainly 
associated with the HDL3 of serum HDL. 
Following infections or injuries, a set of systemic 
physiological responses is initiated, which are 
collectively referred to as the acute-phase response. 
Among others, these include fever, metabolic 
changes in several organ systems, high profile 
protein synthesis in the liver and production of 
proinflammatory cytokines. Together these provide 
optimal conditions for the restoration of 
homeostasis. The apoSAAs are one of the major 
classes of positive acute-phase reactants (A-
apoSAA) for which plasma levels are elevated 
several hundred to several thousand folds during 
acute inflammation and injury (Hoffman and 
Benditt 1982; Kushner 1982). At present, four 
human SAA gene loci have been identified on 
chromosome 11 in this multigene family (Husbey 
et al., 1994). Two of them are acute-phase hyper 
inducible genes (SAA1 and SAA2, which encode 
A-apoSAAs), one is a pseudogene (SAA3) and one 
is expressed constitutively (SAA4, which encodes 
C-SAA) (Steel and Whitehead 1994). 
It has been shown that the synthesis of A-apoSAA 
is induced by proinflammatory cytokines (Betts et 
al 1991). In particular, the acute-phase genes 
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coding for SAAs are regulated by IL-1 or TNF and 
reach the maximum stimulation in the presence of 
interleukin-6 (Grehan et al 1997). While the 
primary source of circulating A-apoSAAs is the 
liver for the systemic acute-phase response 
(Kushner 1982), extrahepatic expression of these 
proteins has been demonstrated in different species 
and in various cell types, such as cultured smooth 
muscle cells, endothelial cells, monocytes, and 
macrophage cell lines (Webb et al 1989; Meek et al 
1994). Therefore, it appears that these cells could 
provide a local source of SAA proteins. The local 
production of A-apoSAA raises the possibility that 
A-apoSAA may play a role related to the site of 
expression rather than to acute-phase systemic 
response. 
This question is especially important in relation to 
the activity of membrane proteins, because losing 
the activity of such systems will ultimately lead to 
malfunction or death of the cell.  In this study, the 
interactions of SAA and SAA protofibrils with 
different cells of the mouse are dealt with in detail 
to study the binding of SAA protofibrils in various 
conditions. Specifically, interaction of amyloid A 
fibrils with a cell surface binding site/receptor might 
alter the local environment to cause cellular 
dysfunction and to be more favorable for amyloid 
formation. Already RAGE (receptor for advanced 
glycation endproducts) a polyvalent receptor in the 
immuglulobulin superfamily has been implicated in 
binding with the isoform of SAA (SAA1.1) which 
has the highest fibirillogenic property. 
II. MATERIALS AND METHODS 
A. Isolation of SAA Protein 
HDL was isolated from the pooled plasma by 
sequential centrifugation (Lindhorst et al 1997). 
Briefly, the density of the plasma was adjusted to 
1.063 g/l with solid KBr, followed by 
centrifugation at 10C for 16 hrs at 75000g in a 
Beckman 50 Ti rotor. The top quarter, which 
contained VLDL and LDL, was aspirated and 
discarded. The pooled infranatants, adjusted to 
solvent density 1.21 g/l by addition of KBr, were 
re-centrifuged for 48 hrs at 106,000g in 50 Ti rotor. 
The top layers (HDL) were aspirated, pooled and 
concentrated with 0.15 M NaCl, 0.1% EDTA, pH 
6.4 for 2 hrs at 40C and then with 10% formic 
acid for 2 hrs using FILTRON. (GELMAN 
Sciences. India). 
B. Gel Chromatography of HDL-SAA Protein 
The concentrated HDL preparation was 
fractionated on a column 2.5 cm  100 cm of 
Sephacryl S-200 (Pharmacia Biotech, Uppsala, 
Sweden) previously equilibrated with 10% (v/v) 
formic acid at a flow rate of 25 mL/hr. 5 mL 
fractions were collected using FPLC (Fast Protein 
Liquid Chromatography) Gradifrac system 
(Pharmacia Biotech, Uppsala, Sweden). Hiload 
pump p-1 fractions were monitored at 280 nm. 
Fractions were pooled and concentrated using 
FILTRON (GELMAN Sciences, India) and freeze-
dried. 
C. Anion Exchange Chromatography 
The freeze dried sample obtained from the gel 
filtration step was dissolved in 10 mM tris (pH 
8.2/8 M urea and was applied to a column (1 cm  
30 cm) of DEAE cellulose (Whatman DE-52) 
previously equilibrated with the same buffer. After 
loading, the column was washed further with 80 
mL of initial buffer, using FPLC Gradifrac 
system (Pharmacia Biotech, Uppsala, Sweden). 
The column was then eluted with a linear gradient 
of 150 mL each at 10mM Tris (pH 8.2)/8 M urea 
and 150 mM Tris (pH 8.2)/8 M urea. The flow rate 
was 12 mL/hr and 3 mL fractions were collected. 
Fractions were pooled and concentrated using 
FILTRON (GELMAN Sciences, India). At the end 
of the gradient, the column was further washed 
with 7.5 mL of 1 M Tris (pH 8.2)/8 M urea. Protein 
was determined by the method of Lowry et al 
(Lowry et al 1951). Fractions were pooled and 
concentrated using FILTRON (GELMAN 
Sciences, India) and freeze-dried. 
D. Characterization of SAA Protein 
Column fractions were analyzed for their potential 
component on 15% (w/v) polyacrylamide gel in 
SDS system as described by Laemmli (1970)
 
and 
10-20% native-PAGE gradient gels system as 
described by Layfield et al (1996).   
E. RP-HPLC 
The RP-HPLC equipment (Kaplan et al 1999) 
consisted of a Waters RP-HPLC pump 515 A and 
B (Waters, Milford, MA, USA) solvent delivery 
system with automated gradient controller coupled 
to a Shimadzu. SPD 10A UV-Visible detector 
(Shimadzu, Kyoto, Japan) with an 8 l cell, a 
waters 746 data module. A Waters Spherisorb ODS 
2 analytical column LC18 25 cm  4.6 mm (Waters, 
Milford, MA, USA) with 20 l sample loop. 
The samples of amyloid protein were suspended in 
aqueous 0.1% TFA in water and filtered in 0.2  
nylon membrane filter. RP-HPLC was performed 
over 45 min with a linear gradient at 77% 
acetonitrile in 0.1% TFA. The effluent was 
monitored at 220 nm.
 
F. Size Exclusion Chromatography (SEC) 
Size exclusion HPLC columns were used to purify 
the amyloid protein, monitored with Shimadzu UV-
Visible detector (Shimadzu, Kyoto, Japan) 
Ultrahydrogel 250, Ultrahydrogel500 7.8  
300 mm column (Waters, Japan). Eluents consist of 
20% acetonitrile 0.1% TFA solution and applied to 
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the sample loop (20 l per run). The elution was 
monitored at 220 nm; with isocratic flow rate at 0.8 
mL/min. Signals were collected from Waters 746 
data module (Waters, Milford, MA, USA).  
G. Generation of SAA fibrils 
Swiss white mice by producing a small sterile 
dorsal subcutaneously injecting 0.5 mL of 10% 
(w/v) Vitamin free Casein (ICN Pharmaceuticals, 
Cleveland, OH, USA) solution under the skin of 
the back (Botto et al 1997; Benson et al 1977). 
After 24 hrs the mice were sacrificed and 
transferred to chilled plate. 
H. Fluorescence Spectroscopy 
Purified SAA and SAA protofibrils (400 g/400 l 
0.001% NH4OH, pH 9.0) were labeled with 
fluorescein isothiocyanate (FITC) (Fluka, USA) by 
dialysis through a 10000 Da cutoff membrane. 
FITC (0.4 mg) was dissolved in 40 l DMSO and 
added to 40 mL of PBS adjusted to pH 9.0 with 
NH4OH. After 12 hrs at 4C the SAA-FITC and 
SAA protofibrils-FITC was dialyzed against milli-
Q water, at 4C (Linke et al 1991). 1.25-6.25 M 
SAA-FITC and SAA protofibrils-FITC assayed for 
fluorescence intensity (FL, at max 53015 nm) 
(PERKIN-Elmer Chemiluminescence, USA).  
I. Single Photon Counting 
1.25-6.25 M SAA-FITC and SAA protofibrils-
FITC assayed for lifetime measurements (FL, at 
max 53015 nm) (Spectra physics, IBH 
Consultants, Scotland, UK).   
J. Induced Circular Dichroic Spectroscopic 
Studies 
1.25-6.25 M SAA-FITC and SAA protofibrils-
FITC assayed for induced CD measurements (Jasco 
J-715 Spectropolarimeter, Tokyo, Japan).   
K. FACScan Analysis 
Neuro 2a cells were incubated with 1.25-6.25 M 
SAA-FITC and SAA protofibrils-FITC assayed for 
24 hrs at 4C, washed in PBS, fixed immediately in 
1% paraformaldehyde in PBS, and assayed for 
cellular fluorescence (FL, at max 53015 nm), 
forward scatter (FSC), and side scatter (SSC). 
Binding was analyzed on a FACScan flow 
cytometer using FACScan analysis software 
WINMDI (Becton Dickinson, San Jose, CA, USA).   
L. MTT Assay 
1.25-6.25 M SAA-FITC and SAA protofibrils-
FITC assayed incubation with Neuro 2a cells for 24 
hrs. Added of 200 l fresh medium at the end of 
the growth period and add 50 l of MTT to all 
wells in columns 1 to 6. Wrap plates in aluminum 
foil and incubate for 4 hrs in a humidified 
atmosphere at 37C. This is a minimum incubation 
time and plates can be left for up to 8 hrs. Remove 
the medium and MTT from the wells and dissolve 
the remaining MTT-formazan crystals, adding 200 
l of DMSO to all wells in columns 1 to 6. Add 
glycine buffer (25 l per well) to all wells 
containing the DMSO. Record absorbance at 570 
nm immediately, since the product is unstable. The 
wells in column 1, which contain medium, MTT, 
but no cells, are used to blank the plate reader.  
III. RESULTS 
Deposition of amyloid A fibrils in tissues resulting 
in the displacement of normal structure and cellular 
dysfunction is the characteristic feature of systemic 
amyloidosis. This work was initiated to explore 
whether SAA monomeric and protofibrillar 
aggregates would bind to the different cell lines 
from mouse Neuro 2a. This was selected as model 
system for parenchymal cerebral cortex system 
where localized amyloid seems to be the maximum 
effect. The use of parenchymal cells for the study 
of SAA gains importance as the SAA expression is 
observed in the parenchymal cells in the 
inflammatory condition (Guo et al 2002). It has 
shown in under the systemic amyloid condition the 
serum amyloid protofibrils pass the blood brain-
barrier and bind widely in the parenchymal region 
(Asokan 2014). It is also observed that the crossing 
of BBB is accompanied by the expression of A 
peptides 20 times more than the control indicating 
the importance of the SAA interaction to the cells 
of parenchymal origin. Further, since SAA the 
value dramatically increased in the systemic 
circulation during the infection condition their 
interaction with the cell lines gains importance 
(Yamada 1999). Binding SAA of protein and AA 
protofibirls seemingly target the membranes (Yan 
et al 2000). Immediately after synthesis, the SAA is 
released from the cell and binds with HDL and is 
never found in the free form. In the circulation it is 
rapidly cleared: its half-life in mice is 30-50 min 
faster than apolipoprotein (Benson et al 1995; 
Kluve-Beckerman et al 1997). As the amyloid 
toxicity depends upon the assembled state of the 
protein in this study measured the cell-protein 
interaction in both monomer and assembled form. 
To determine the interaction in this study 
conjugated the proteins with FITC, which could be 
identified by fluorescence and absorption, 
distinctly. 
A. Fluorescence spectroscopy 
SAA-FITC binding to each other was studied using 
fluorescence intensity changes. The binding 
activity of protein was detected using fluorescence 
spectral change. The principle of the method is 
based on the reported phenomenon of fluorescence 
quenching in the protein abundantly labeled by 
fluorophores (this phenomenon is caused by an 
interaction of aromatic rings of different 
fluorophore molecules and interaction of disulfide 
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bonds with fluorophores) and the fluorescence 
increases greatly after polypeptide chain breaks 
occur. The signal change in FITC fluorescence is 
applied here to study the nature of interaction of 
serum amyloid components with each other. The 
SAA is covalently linked to FITC. Typical increase 
in fluorescence spectra was observed on increasing 
the SAA-FITC concentration. At higher SAA-FITC 
concentration, the self-quenching of fluorescence 
was observed (Fig. 1a). Linear increase in FITC 
fluorescence was observed during addition of SAA 
protofibril-FITC. This linear increase was diminished 
after addition of SAA-FITC protofibril at a 
concentration greater than 5 M. The deviation of 
fluorescence curve may be associated with 
aggregation of SAA protofibril resulted in interaction 
of aromatic side chains with each other near the 
fluorophore (Fig. 1b).  
 
Fig. 1a. Fluorescence spectra of SAA-FITC (a) 
SAA-FITC with increasing concentrations of 
(1.25-6.25 µM) SAA-FITC and insert plot shows 
(1.2-6.25 µM) concentration Vs Fluorescence 
 
Fig. 1b. Fluorescence spectra of SAA protofibrils-
FITC (b) SAA protofibrils-FITC with increasing 
concentrations of (1.25-11.25 µM) SAA 
protofibrils-FITC and insert plot shows (1.2-6.25 
µM) concentration Vs Fluorescence. 
B. Fluorescence Lifetime Measurements 
The fluorescence life of a fluorophore depends 
strongly on the properties of the molecules 
surrounding the probe. A decrease in fluorescence 
intensity followed by a decrease of the lifetime 
suggests an increase in excitation energy transfer, a 
photochemical reaction or other quenching 
processes. One of the most widely used 
fluorophores to label proteins for structural and 
conformational studies is fluorescein isothiocyante 
(FITC). Fluorescence dyes differ in their ability to 
quench. The more hydrophobic the dye the lower 
ratio of dye: protein where quenching will occur. 
The effect of SAA concentration on lifetime of 
FITC is indicated in Fig.2a.  The average 
fluorescence lifetime increased from 2.5 to 3.3 ns 
indicating that the fluorophore is in highly polar 
environment than in the previous state. In high 
SAA concentration (6.25 M), the association of 
SAA results in exposure of more FITC to the polar 
environment. The amplitude for short lifetime (1) 
was decreased significantly from 45% to 30% 
during addition of SAA protein (Fig. 2b). However, 
long-lived species increased from 38 to 47% during 
further SAA incubation. 
 
Fig. 2. Life time measurements of fluorescence 
decay of SAA-FITC (a) with increasing 
concentration of (1.25-6.25 µM) SAA-FITC, (b) 
increasing concentration of (1.25-6.25 µM) SAA-
FITC Vs Amplitude and insert plot shows (1.2-
6.25 µM) concentration Vs time. 
C. Induced CD Measurements 
The CD spectrum of SAA-FITC, which was 
concentration-dependent, is shown in Fig. 3a. The 
association SAA at different concentrations altered 
the CD band at 450 and 505nm and became 
maximal at 1.25nM of SAA. Further addition of 
SAA did not alter the Molar ellipticity. The SAA-
FITC protofibrils addition decreased the positive 
band at 450 nm and increased the negative band 
505 nm (Fig. 3b).  There was no significant change 
in the CD band at 450 nm indicated in plot.  
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Fig. 3a. CD spectra of SAA-FITC SAA-FITC with 
increasing concentration of (1.25-6.25 µM) SAA-
FITC and insert plot shows (1.25-6.25 µM) 
concentration Vs elipticity at 450 and 505 nm 
 
Fig. 3b. CD spectra of SAA protofibrils-FITC 
SAA protofibrils-FITC with increasing 
concentration of (1.25-6.25 µM) SAA protofibrils-
FITC and insert plot shows (1.25-6.25 µM) 
concentration Vs elipticity at 450 and 505 nm 
 
 
 SAA Protofibrils 
Fig. 4. Viability test for the SAA protein (1.25-
6.25 µM) (a) neuro 2a cells (b) Viability test for 
the SAA protofibrils (1.25-6.25 µM). 
D. Binding Study of Monomeric and Protofibrils 
of SAA to Neuro 2a Cells of Mouse 
Viability test for the SAA protein (1.25-6.25 µM) 
(Fig. 4a) Neuro 2a cells (Fig. 4b) Viability test for 
the SAA protofibrils (1.25-6.25 µM). SAA-FITC 
binding to Neuro 2a cells was analyzed by flow 
cytometry and the respective histogram is shown in 
Fig. 5a and b. The shifting of cell population towards 
higher fluorescence side in the histogram reveals the 
binding of monomeric SAA-FITC to cell 
populations. The forward and side scatter is not 
changed significantly indicating that volume and 
granularity is not affected during serum amyloid 
binding to the respective cell lines. SAA protofibril-
FITC also binds to Neuro 2a cells similar to 
monomeric SAA as shown in cytometry histogram 
(Fig. 5b).  
 
 
 
Fig. 5. Fluorescence histogram of SAA-FITC and 
SAA protofibrils-FITC in mouse neuro 2a cells 
(a) histogram shows filled curve control cells, 
black curve shows SAA-FITC (2.5 µM), violet 
curve shows increasing concentration of SAA-
FITC (6.25 µM),  (b) histogram shows filled 
mouse neuro 2a cells, black curve shows SAA 
protofibrils-FITC (2.5 µM), red curve shows 
increasing concentration of SAA protofibrils-
FITC (6.25 µM). 
Table: 1. Determination of affinity 
constant (Kd) 
Cell 
type 
Monomeric SAA   
(M) 
Protofibrillar SAA 
(M) 
Neuro 
2a 
0.65 0.8 
Affinity constants (Wang et al 1996) for monomeric 
and fibrillar SAA-FITC were calculated from the 
flow cytometry experiments given in table 1. The 
affinity constants for SAA-FITC in monomeric and 
fibrillar form remains same in all the cell lines 
indicating the presence of high affinity binding 
sites for serum amyloid in both the forms. 
Concentration dependent toxicity was observed in 
SAA binding. (Fig. 4a and 4b), show the changes 
in cell viability induced by exposure to 1.25-6.25 
M SAA for 24 hrs caused significant cell death. 
Incubation of varying concentrations of SAA 
resulted in Neuro 2a cells, only 50% viable Neuro 
2a cells at 4–6 M with an LD50 of 3.5 M.  
IV. DISCUSSION 
The multi exponential decay of SAA-FITC is 
possibly due to heterogeneity of conformational 
isomers of the protein, time dependent relaxation 
around the excited state, or the intrinsic 
heterogeneity of the FITC around the SAA protein. 
SAA is showing heterogeneity because it contains 
three additional lysine molecules labeled FITC 
together with amino terminal region on the protein 
molecule.  
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For many fluorophores, intermolecular interactions 
and energy transfer between molecules in close 
proximity to one another result in self-quenching. 
Molecular association can be assessed, if during 
this process, the molecular environment changes 
around the fluorescent probes used to label the 
desired protein. Using polarity changes near the 
probe, accessibility of the binding site of the 
protein by various molecules of interest can be 
evaluated. Conformational change of the 
fluorophore (FITC) induced by binding of proteins 
can cause a change in the fluorescence intensity. 
Time resolved fluorescence spectroscopy enables 
the independent observation of different 
populations of a fluorophore (free or protein 
bound) in contrast to the steady state fluorescence 
spectroscopy.  
Flow cytometric analysis suggested that interaction 
of SAA with its receptor on Neuro 2a was stronger. 
Moreover, FITC labeled SAA was found to bind, in 
a saturable manner, to all the cells, reaching a 
binding affinity of ~10
-9 
M. Although the chemical 
structure of SAA is defined, presence of its putative 
receptor on various target cells is unknown. 
Previous research work has shown that SAA acts as 
a chemo attractant and regulator of the migration of 
monocytes, polymorphonuclear cells, and 
lymphocytes through its avid interaction. The 
human SAA binds to T lymphocytes with a 
dissociation constant Kd=10
-9 
M. 
The principal role of SAA during the acute-phase 
reaction appears to be the association with HDL-
particles and subsequent changes of apolipoprotein 
composition and metabolic properties of its 
physiological carrier. Because SAA may displace 
apolipoprotein A-I, the major apolipoprotein of 
HDL, it is hypothesized that SAA could alter the 
protective function of HDL during ‘reverse 
cholesterol transport (Artl 2000). SAA binding 
acute phase reaction was studied with macrophages 
(representative peripheral cells) revealed that the 
binding affinity for SAA is enhanced. Earlier 
findings suggest that extracellular matrix proteins 
appear to serve as a temporary anchorage sites for 
SAA and amyloid A. (Preciado-Patt et al 1996). 
Though SAA exists predominantly with HDL, its 
physiological function is unknown.  From the side 
scatter and forward scatter values of SAA treated 
cells, it is clear that SAA binding does not alter the 
size and granularity of cells. Moreover, SAA had 
no effect on either protein synthesis or DNA 
synthesis, suggesting that SAA specifically altered 
lipid synthesis. Earlier findings suggest that acute-
phase SAA down-regulates lipid biosynthesis in 
cultured aortic smooth muscle cells in a time and 
dose-dependent manner.  
For SAA, the situation is different since SAA, an 
acute phase reactant, rapidly integrates into HDL. 
Since HDL are potent LPS neutralizing entities by 
themselves. Studying the LPS-SAA interaction in 
acute phase sera will help to elucidate the exact 
role for SAA. In a clinical study the exact ratio of 
free and HDL-associated SAA will be determined 
in septic patients.  
The SAA proteins comprise a family of molecules 
that are apolipoproteins being primarily associated 
with HDL. Triggered by inflammation, e.g. tissue 
damage or infection and after stimulation of 
hepatocytes by cytokine-mediated processes, the 
concentrations of SAA may increase during the 
acute-phase reaction to levels 1000-fold greater 
than those found in the noninflammatory state. The 
principal role of SAA during the acute-phase 
reaction appears to be the association with HDL-
particles and subsequent changes of apolipoprotein 
composition and metabolic properties of its 
physiological carrier. Because SAA may displace 
apolipoprotein A-I, the major apolipoprotein of 
HDL, it is hypothesized that SAA could alter the 
protective function of HDL during ‘reverse 
cholesterol transport. During this process native 
HDL is able to bind to peripheral cells and then to 
promote cholesterol efflux. Subsequently, acquired 
cholesterol is transferred either to lipoproteins 
other than HDL or directly transported to the liver. 
The major findings of the present study are as 
follows: (1) Binding studies demonstrated that 
during the acute-phase reaction binding affinity and 
holoparticle uptake of HDL by J774 macrophages 
(a representative of peripheral cells) is enhanced, 
whereas HUH-7 Hepatoma cells (a representative 
of liver cells mediating uptake of HDL-associated 
cholesterol) have decreased affinity and HDL-
holoparticle uptake (2) The presence of A-SAA on 
HDL specifically increases selective uptake of 
HDL-associated cholesterylester and holoparticle 
uptake by J774 macrophages. In contrast to these 
findings, the selective uptake of HDL-associated 
cholesterylester and holoparticle uptake by HUH-7 
cells was decreased during the acute-phase 
reaction. (3) During cholesterol efflux experiments, 
it became apparent that the ability of acute-phase 
HDL with regard to cellular cholesterol removal 
from J774 macrophages was considerably lowers 
(30-35%) than for native HDL. In contrast, HDL-
mediated cholesterol efflux from the plasma 
membrane of HUH-7 cells was slightly enhanced 
by acute-phase HDL. (4) Using ligand blotting 
experiments, two binding proteins for native and 
acute-phase HDL on J774 macrophages with 
molecular masses of 100 and 72 kDa could be 
observed. A single binding protein of 100 kDa 
could be observed on HUH-7 cells. Collectively, 
the present findings support the hypothesis that A-
SAA may command HDL-particles during the 
acute-phase reaction to peripheral cells. 
Subsequently, the net transfer of cholesterol during 
the acute-phase reaction seems to be directed 
towards macrophages. It seems that changes in the 
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apolipoprotein moiety of HDL appear to transform 
an originally antiatherogenic HDL-particle into a 
proatherogenic lipoprotein particle.   
In the present study, we sought to define the region 
of acute phase apoSAA involved in cholesterol 
binding and to investigate the ability of constitutive 
apoSAA4 to bind cholesterol. Binding of [3H] 
cholesterol to apoSAAp was inhibited by unlabeled 
cholesterol (1-100 nM), but not significantly by 
vitamin D and estradiol. Direct binding of acute 
phase, but not constitutive, apoSAA to the surfaces 
of polystyrene microtiter wells was strongly 
diminished in the presence of cholesterol. The 
ability of apoSAA to bind cholesterol was inhibited 
by antibodies to human apoSAA1 and to peptide 1-
18 of apoSAA1. There was only slight inhibition of 
cholesterol binding by antibodies to peptide 40-63, 
and no inhibition by antibodies to peptides 
spanning regions containing amino acid residues 
14-44 and 59-104. [3H] Cholesterol uptake by 
neonatal rabbit aortic smooth muscle and HepG2 
cells was enhanced by a synthetic peptide 
corresponding to amino acids 1-18 of hSAA1, but 
not by peptides corresponding to amino acids 1-18 
of hSAA4. [3H] Cholesterol uptake by HepG2 cells 
was slightly increased by a peptide corresponding 
to amino acids 40-63 of hSAA1. These findings 
suggest that apoSAA modulates the local flux of 
cholesterol between cells and lipoproteins during 
inflammation and atherosclerosis (Liang and Sipe 
1995) 
The this study data reported here demonstrate that 
SAA and amyloidotic AA bind with cholesterol 
rich region of brain cells, Neuro 2a cells of the 
brain. Previous workers have observed that acute-
phase SAA binds and transports cholesterol into 
Neuro 2a and HepG2 cells (Liang and Sipe 1995; 
Liang et al 1996) suggesting that SAA might have 
a role in cholesterol homeostasis during chronic 
inflammation in diseases including atherosclerosis.  
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